
|Articles|December 27, 2021
Daily Medication Pearl: Benicar (Olmesartan Medoxomil)
Author(s)Saro Arakelians, PharmD
Benicar (Olmesartan Medoxomil) is indicated for the treatment of hypertension.
Advertisement
Medication Pearl of the Day:Benicar (Olmesartan Medoxomil)
Indication: Benicar (Olmesartan Medoxomil) is an angiotensin II receptor blocker indicated for the treatment of hypertension, alone or with other antihypertensive agents, and is used to lower blood pressure.
Insight:
- Dosing: Benicar (Olmesartan Medoxomil) can be taken at 20 mg to 40 mg daily.
- Dosage forms: Benicar (Olmesartan Medoxomil) comes in dosage forms at 5 mg, 20 mg, and 40 mg.
- Adverse events (AEs): The most common AE in adult patients is dizziness.
- Mechanism of action: Benicar (Olmesartan Medoxomil) works by blocking the vasoconstrictor effects of angiotensin II by selectively blocking the binding of angiotensin II to the angiotensin II receptor type 1 in vascular smooth muscle.
- Manufacturer: Daiichi Sankyo
Source:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Updates in Treatment of Unresectable Hepatocellular Carcinoma
2
Soaring off the Patent Cliff: Preparing for the Next Wave of Oncology Biosimilars
3
FDA Approves Depemokimab as Add-On Maintenance Treatment in Severe Asthma
4
Infliximab and Adalimumab Biosimilars Maintain Comparable Safety, Efficacy, Immunogenicity in IBD
5











































































































































































































